** Stifel Financial SF.N stock down 2.9% after co ordered to pay $132.5 mln for misrepresenting risk of complex structured notes
** Financial Industry Regulatory Authority arbitration panel awarded $26.5 mln in compensatory damages, $79.5 mln in punitive damages, and $26.5 mln for legal fees to the Jannetti family
** Value of the notes was linked to the SPDR S&P Biotech ETF XBI.P and stocks including DocuSign DOCU.O, Dynatrace DT.N, Palantir Technologies PLTR.O and Twilio TWLO.N
** Stifel plans to appeal, arguing the Jannettis were experienced investors who understood risks and only complained after losses
** SF's stock has declined about 13% YTD, compared to a 6% fall in S&P 500 .SPX
** Stock is about 23% below its 52-week intraday high of $120.27 reached on Jan. 30, 2025
** Stock recently traded at 11 times expected earnings, in line with its 5-year avg forward PE of 11, per LSEG data
(Reporting by Noel Randewich)
((noel.randewich@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.